Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
6
Number of overlapping holdings
13.0%
% of IDNA's 49 holdings also in XDNA
26.1%
% of XDNA's 23 holdings also in IDNA
Overlap by Weight
Sector Drift (IDNA minus XDNA)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in IDNA |
Weight in XDNA |
Overlap | |
|---|---|---|---|---|
 |
SANOFI-AVENTIS | 4.1% | 3.2% | 3.2% |
 |
BEAM THERAPEUTICS, INC. | 2.2% | 13.7% | 2.2% |
|
REGENERON PHARMACEUTICALS | 4.3% | 1.3% | 1.3% |
|
CRISPR THERAPEUTICS AG | 1.1% | 15.1% | 1.1% |
|
INTELLIA THERAPEUTICS, INC. | 0.6% | 8.7% | 0.6% |
Position Highlights (Non-Overlapping Exposures)
IDNA Overweight Relative to XDNA
|
SAREPTA THERAPEUTICS INC | 4.8% |
 |
ROCHE HOLDING LTD | 4.7% |
|
REVOLUTION MEDICINES, INC. | 4.6% |
|
GILEAD SCIENCES INC | 4.5% |
|
INCYTE CORP | 4.5% |
|
EXELIXIS INC | 4.2% |
 |
TAKEDA PHARMACEUTICAL CO LTD | 4.0% |
 |
GENMAB A/S | 3.9% |
|
MERCK & CO. INC. | 3.9% |
 |
GSK PLC | 3.8% |
IDNA Underweight Relative to XDNA
|
CRISPR THERAPEUTICS AG | -14.0% |
|
BEAM THERAPEUTICS, INC. | -11.4% |
|
THERMO FISHER SCIENTIFIC INC | -9.5% |
|
INTELLIA THERAPEUTICS, INC. | -8.1% |
|
PRIME MEDICINE, INC. | -5.9% |
|
EDITAS MEDICINE, INC. | -5.2% |
|
CARIBOU BIOSCIENCES, INC. | -4.7% |
|
VERVE THERAPEUTICS, INC. | -4.5% |
|
POSEIDA THERAPEUTICS, INC. | -4.1% |
|
ABBVIE INC | -3.8% |